pentobarbital will lessen the level or impact of verapamil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
fentanyl intranasal and pentobarbital both improve sedation. Avoid or Use Alternate Drug. Limit use to clients for whom option cure possibilities are insufficient
Reserve concomitant prescribing of those medications in clients for whom other remedy alternatives are inadequate. Limit dosages and durations on the bare minimum necessary. Watch closely for indications of respiratory depression and sedation.
pentobarbital will lower the level or outcome of amlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the extent or outcome of conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will minimize the level or effect of triamcinolone acetonide injectable suspension by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
Comment: Barbiturates may raise adverse consequences, such as respiratory despair, made by poisonous doses of TCAs. With therapeutic doses of TCAs, barbiturates boost metabolism and reduce order Nembutal Products Online blood concentrations of TCAs.
pentobarbital will decrease the level or outcome of quinidine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital raises toxicity of methoxyflurane by rising metabolism. Contraindicated. Enhanced metabolism of methoxyflurane to nephrotoxic compounds.
Contraindicated (1)pentobarbital will reduce the level or effect of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will increase outcomes of ifosfamide by influencing hepatic enzyme CYP2B6 metabolism. Use Warning/Observe. Coadministration of ifosfamide with CYP2B6 inducers may well maximize metabolism of ifosfamide to its metabolite. Keep an eye on for elevated consequences/toxicities if coupled with CYP2B6 inducers.
pentobarbital will decrease the extent or result of ambrisentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.
pentobarbital will minimize the level or outcome of dutasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
pentobarbital will minimize the extent or impact of atorvastatin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.